Astellas Pharma

Dr. Peter Carberry has been appointed senior vice president and head of global development operations, Astellas Pharma Global Development (APGD). Dr. Carberry is responsible for enhancing the effectiveness and efficiency of the integrated global operational platform including the data sciences and clinical operations organizations.

“We are pleased that Peter has joined Astellas and we know that he will contribute significantly to the development of innovative products,” said Dr. Steven Ryder, president of APGD. Peter is one of several key hires at APGD that were brought on to strengthen and accelerate our research and development function.

Prior to joining the company, Dr. Carberry was the vice president of clinical operations, development planning and performance analysis and the office of international development at Genentech. In that role, he developed a global platform for the execution of non-clinical and clinical activities and established key relationships with company stakeholders. Previously, he was the senior vice president of global clinical operations at Johnson & Johnson Pharmaceutical R&D. Dr. Carberry began his industry career with Pharmacia at the Kalamazoo Research site.